KLHDC8A and central nervous system cancer: When KLHDC8A overexpressed glioma cells were pretreated with ERK inhibitor U1026 and p38 MAPK inhibitor SB203580,26, 27 phosphorylation of ERK and p38 MAPK was depressed.